Loading…
Benefit‐risk assessment for sofosbuvir/velpatasvir/voxilaprevir based on patient population and hepatitis C virus genotype: U. S. Food and Drug Administration's evaluation
Struble, Kimberly, Chan‐Tack, Kirk, Qi, Karen, Naeger, Lisa K., Birnkrant, Debra
Published in Hepatology (Baltimore, Md.) (01.02.2018)
Published in Hepatology (Baltimore, Md.) (01.02.2018)
Get full text
Journal Article
Loading…
Loading…
Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment
Khatri, Amit, Dutta, Sandeep, Marbury, Thomas C., Preston, Richard A., Rodrigues, Lino, Wang, Haoyu, Awni, Walid M., Menon, Rajeev M.
Published in Clinical pharmacokinetics (01.02.2017)
Published in Clinical pharmacokinetics (01.02.2017)
Get full text
Journal Article
Loading…
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis
Chen, Chun-Hsien, Chen, Chien-Hung, Lin, Chih-Lang, Lin, Chun-Yen, Hu, Tsung-Hui, Tung, Shui-Yi, Hsieh, Sen-Yung, Lu, Sheng-Nan, Chien, Rong-Nan, Hung, Chao-Hung, Sheen, I-Shyan
Published in Scientific reports (08.05.2019)
Published in Scientific reports (08.05.2019)
Get full text
Journal Article
Loading…
Impact of interferon‐free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real‐life cohort
Álvarez‐Ossorio, M. J., Sarmento e Castro, R., Granados, R., Macías, J., Morano‐Amado, L. E., Ríos, M. J., Merino, D., Álvarez, E. N., Collado, A., Pérez‐Pérez, M., Téllez, F., Martín, J. M., Méndez, J., Pineda, J. A., Neukam, K., Alados‐Arboledas, Juan Carlos, Albendín, Helena, Alemán, María Remedios, Alonso, María del Mar, Asensi, Victor, Blanco, María José, Cabo, Rebeca, Camacho, Ángela, Casas, Mario Frías, Castro, Ángeles, Cervantes, Manuel, Cucurull, Josep, Cuéllar, Sandra, Cuenca, Francisca, Delgado, Marcial, Domínguez, Lara, Dueñas, Carlos, Fernández, Elisa, Galera, Carlos, Gálvez, María Carmen, García, Dácil, Martínez, Paloma Geijo, Gómez, Ana, Gómez, Juan Luis, Gutiérrez, Félix, Hernández, José, Hernández, Jehovana, Llenas‐García, Jara, Márquez, Manuel, Martínez, Lorena, Martínez‐Álvarez, Rosa, Madrid, Onofre Martínez, Masiá, María del Mar, Merchante, Nicolás, Mínguez, Carlos, Montero‐Alonso, Marta, Omar, Mohamed, Ortega, Enrique, Padilla, Sergio, Robledano, Catarina, Pelazas, Ricardo, Pérez‐Camacho, Inés, Pernas, Berta, Portilla, Joaquín, Portu, José Joaquín, Raffo, Miguel, Real, Luis Miguel, Reina, Gabriel, Reus, Sergio, Rincón, Pilar, Rivero, Antonio, Rivero‐Juárez, Antonio, Romero‐Palacios, Alberto, Rubio, Purificación, Ryan‐Murua, Pablo, Saíz de la Hoya, Pablo, de los Santos‐Gil, Ignacio, Santos, Jesús, Saussol, Fernando, Serrano, Miriam, Toyas, Carla, Vera‐Méndez, Francisco Jesús, Hernández, Marina Villalobos, García, David Vinuesa
Published in Journal of viral hepatitis (01.06.2018)
Published in Journal of viral hepatitis (01.06.2018)
Get full text
Journal Article
Loading…
Drug-Drug Interactions between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir with or without Dasabuvir
King, Jennifer R., Dutta, Sandeep, Cohen, Daniel, Podsadecki, Thomas J., Ding, Bifeng, Awni, Walid M., Menon, Rajeev M.
Published in Antimicrobial agents and chemotherapy (01.02.2016)
Published in Antimicrobial agents and chemotherapy (01.02.2016)
Get full text
Journal Article
Loading…
Real-World Efficacy and Safety of Ritonavir-Boosted Paritaprevir, Ombitasvir, Dasabuvir ± Ribavirin for Hepatitis C Genotype 1 – Final Results of the REV1TAL Study
Lubel, John, Strasser, Simone, Stuart, Katherine A, Dore, Gregory, Thompson, Alexander, Pianko, Stephen, Bollipo, Steven, Mitchell, Joanne L, Fragomeli, Vincenzo, Jones, Tracey, Chivers, Sarah, Gow, Paul, Iser, David, Levy, Miriam, Tse, Edmund, Gazzola, Alessia, Cheng, Wendy, Nazareth, Saroj, Galhenage, Sam, Wade, Amanda, Weltman, Martin, Wigg, Alan, MacQuillan, Gerry, Sasadeusz, Joe, George, Jacob, Zekry, Amany, Roberts, Stuart K
Published in Antiviral therapy (01.01.2017)
Published in Antiviral therapy (01.01.2017)
Get full text
Journal Article
Loading…
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study
Janczewska, Ewa, Zarębska-Michaluk, Dorota, Berak, Hanna, Piekarska, Anna, Gietka, Andrzej, Dybowska, Dorota, Mazur, Włodzimierz, Belica-Wdowik, Teresa, Dobracki, Witold, Tudrujek-Zdunek, Magdalena, Deroń, Zbigniew, Buczyńska, Iwona, Sitko, Marek, Czauż-Andrzejuk, Agnieszka, Lorenc, Beata, Białkowska-Warzecha, Jolanta, Citko, Jolanta, Laurans, Łukasz, Jaroszewicz, Jerzy, Socha, Łukasz, Tronina, Olga, Adamek, Brygida, Horban, Andrzej, Halota, Waldemar, Baka-Ćwierz, Barbara, Tomasiewicz, Krzysztof, Simon, Krzysztof, Garlicki, Aleksander, Wawrzynowicz-Syczewska, Marta, Flisiak, Robert
Published in BMC infectious diseases (16.11.2018)
Published in BMC infectious diseases (16.11.2018)
Get full text
Journal Article
Loading…
Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study
Lasseter, Kenneth C, Shaughnessy, Laura, Cummings, David, Pezzullo, John C, Wargin, William, Gagnon, Rene, Oliva, Jesus, Kosutic, Gordana
Published in Journal of clinical pharmacology (01.02.2008)
Published in Journal of clinical pharmacology (01.02.2008)
Get more information
Journal Article
Loading…
Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected Patients
Khatri, Amit, Mensing, Sven, Podsadecki, Thomas, Awni, Walid, Menon, Rajeev, Dutta, Sandeep
Published in Clinical drug investigation (01.08.2016)
Published in Clinical drug investigation (01.08.2016)
Get full text
Journal Article